Skip to content

Cornea & Keratoconus

Corneal Cross-Linking: Stopping Keratoconus in Its Tracks

Corneal cross-linking is the only treatment shown to stop keratoconus from progressing. Riboflavin (vitamin B2) drops are applied to the cornea and activated with a controlled dose of ultraviolet light, creating new bonds between the collagen fibers that stiffen the cornea. It is an outpatient procedure of typically about an hour, performed with numbing drops, with a sore, light-sensitive recovery of several days. It preserves the cornea you have; specialty lenses then provide the vision.

Medically reviewed by Dr. Bavand Youssefzadeh, DO

Purpose
Halt progression; not to sharpen vision
Procedure
About an hour, numbing drops
Recovery
Sore for 3 to 5 days; vision settles over weeks
Success
Studies report progression halted in most treated eyes

How cross-linking works

Keratoconus weakens the bonds between the collagen fibers of the corneal stroma, and the cornea bulges under normal eye pressure. Cross-linking restores strength chemically. Riboflavin absorbed into the cornea acts as a photosensitizer: when ultraviolet A light is applied at a set intensity and time, it generates reactive oxygen that forms new covalent bonds within and between the collagen fibers. The stiffened cornea resists further steepening. Studies report the effect is long lasting in most treated eyes.

The procedure

Numbing drops are placed and the eye is held open with a small speculum. In the standard, FDA approved epithelium-off technique, the surface epithelium is gently removed so the riboflavin can penetrate, and riboflavin drops are applied every few minutes for about 20 to 30 minutes until the stroma is saturated. Corneal thickness is checked; a thin cornea is swollen with hypotonic riboflavin to protect the inner layers. The ultraviolet light is then applied for a set period, with riboflavin continuing throughout. A bandage contact lens and antibiotic and anti-inflammatory drops finish the procedure. Total time is typically about an hour, and you go home with a driver.

Recovery

The first three to five days are sore, watery and light sensitive while the epithelium regrows, similar to PRK; prescribed pain relief and drops manage it, and most patients take the week off. The bandage lens is removed once the surface has healed. Vision is blurrier than before treatment for the first weeks, often for a month or two, then recovers to the pre-treatment level and in some patients improves slightly as the cornea flattens over the following year. Contact lenses are refitted once the cornea has stabilized, usually at one to three months. Tomography is repeated at six and twelve months and then annually to confirm the cornea has held.

Who should have it

Patients with keratoconus that is progressing on tomography, or, after discussion with the cornea specialist, young patients with clear disease in whom progression is likely, provided the cornea is thick enough to treat safely and is not scarred centrally. It is also used for ectasia after LASIK. Adults whose keratoconus has been stable for years usually do not need it. Cross-linking is not a vision correction procedure; it is about keeping the cornea you have.

Safety and results

Cross-linking has been performed since the early 2000s and has a strong safety record. Published studies report progression halted in most treated eyes, with a small proportion needing retreatment. Risks include infection while the surface is healing, temporary haze, and, rarely, delayed healing or a persistent surface defect, all of which are why the procedure is performed by a cornea specialist with close follow-up.

Is this right for your eyes?

Nothing on this page is a diagnosis. Whether this is the right choice for you is decided by a full examination at one of our 4 offices: Pasadena, Huntington Beach, Woodland Hills and Beverly Hills.

About this content: This page was written with the assistance of AI tools and reviewed for medical accuracy by Dr. Bavand Youssefzadeh, DO. It is general information, not medical advice, and does not replace an eye examination. Individual results vary. Read our medical disclaimer.

Related pages

Corneal topography measured during a keratoconus evaluationModel

Frequently Asked Questions

Its purpose is to stop progression. Some patients see a modest improvement as the cornea flattens slightly over the following year, but glasses or specialty lenses remain the way vision is corrected.

The FDA approved procedure for progressive keratoconus is often covered by medical insurance, sometimes with prior authorization. Our team checks your coverage and helps with insurance paperwork where needed.

They are usually treated separately, a few weeks apart, so one eye is comfortable during the other's recovery. Both eyes are treated if both are progressing.

Epithelium-off, in which the surface is removed, is the FDA approved and best studied technique, and the one the cornea specialist will discuss first. Epithelium-on variants aim for a gentler recovery; evidence for their long term effectiveness is still developing.

Generally no; the cornea remains keratoconic and LASIK is not appropriate. Once stable, a topography guided surface treatment may smooth some corneas in selected cases, which the cornea specialist evaluates, and, in carefully selected stable eyes after physician evaluation, the EVO ICL can correct the prescription without touching the cornea.

What patients say about us

Model

Ready To See Clearly?

Your consultation is free, by video or in person. You leave with a personal plan, a written quote and 0% financing options.

Contact Us

We encourage you to contact us with any questions or comments you may have. Call us at (855) 456-2253 or use the quick contact form below.